Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem ; 12(22): 5941-7, 2004 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-15498670

RESUMEN

A series of potential DNA-binding antitumor agents, 2-[omega-(alkylamino)alkyl]-9-methoxy-5-nitro-2,6-dihydroindazolo[4,3-bc][1,5]naphthyridines (2a-f), 10-aza derivatives of PZA, has been prepared by condensation of 9-chloro-2-methoxy-6-nitro-5,10-dihydrobenzo[b][1,5]naphthyridin-10-one (6) with the appropriate (omega-aminoalkyl)hydrazine in tetrahydrofuran/methanol. Compound 6 was obtained by heating at 100 degrees C in H(2)SO(4)5, yielded by the condensation of 2,6-dichloro-3-nitrobenzoic acid (4) and 6-methoxy-3-pyridinamine (3). The non-covalent DNA-binding properties of 2 have been examined using a fluorometric technique. In vitro cytotoxic potencies of these derivatives against human hormone-refractory prostate adenocarcinoma cell line (PC-3) are described and compared to that of parent drug PZA. We selected the most cytotoxic target derivatives 2c,d, the in vitro inactive 2f, and reference compound PZA to investigate whether in vitro treatment with these drugs was able to induce necrotic and/or apoptotic cell death. To this purpose, we evaluated the percentage of apoptotic cells in PC-3 treated with the target compounds 2c,d,f and reference compound PZA, by Annexin V staining and Propidium iodide (PI)/Annexin V, biparametric flow cytometric analysis and agarose gel electrophoresis.


Asunto(s)
Antineoplásicos/clasificación , Antineoplásicos/síntesis química , Naftiridinas/clasificación , Naftiridinas/síntesis química , Animales , Antineoplásicos/farmacología , Bovinos , Línea Celular Tumoral , Evaluación Preclínica de Medicamentos/métodos , Humanos , Naftiridinas/farmacología
2.
J Biochem Biophys Methods ; 54(1-3): 235-43, 2002 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-12543501

RESUMEN

A chiral stationary phase (CSP) recently developed by bonding (diphenyl-substituted 1,1'-binaphthyl) crown ether to silica gel for the liquid chromatographic separation of enantiomers was applied to the resolution of investigational fluoroquinolone antibacterial agents including gemifloxacin (formerly LB20304a). All fluoroquinolone compounds used in this study were resolved quite well on the CSP. Especially, the resolution of gemifloxacin and its analogs on the CSP was excellent and even greater than that on the commercial Crownpak CR(+). The resolution was found to be dependent on the type and the content of organic, acidic, and inorganic modifiers added to the mobile phase and on the column temperature.


Asunto(s)
Antiinfecciosos/análisis , Cromatografía Líquida de Alta Presión/métodos , Éteres Cíclicos , Fluoroquinolonas , Coloración y Etiquetado/métodos , Antiinfecciosos/química , Antiinfecciosos/clasificación , Antiinfecciosos/aislamiento & purificación , Cromatografía Líquida de Alta Presión/instrumentación , Estudios de Factibilidad , Gemifloxacina , Naftiridinas/análisis , Naftiridinas/química , Naftiridinas/clasificación , Naftiridinas/aislamiento & purificación , Control de Calidad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Soluciones/química , Estereoisomerismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA